Translate
Propanc Biopharma, Inc.
About
Propanc Biopharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 24 2026
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
Mar 12 2026
Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy
Mar 10 2026
Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
Mar 3 2026
Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models
Feb 18 2026
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Recent Videos
Cómo invertir en Propanc Biopharma Inc (PPCB) paso a paso
Apr 07, 2026
Propanc Biopharma, Inc. (PPCB) #ProenzymeTherapy #Biotech #Nasdaq #CancerResearch #PancreaticCancer
Mar 12, 2026
My
Feb 27, 2026
17 Years of Grind… And One Mother's Story Kept Him Fighting
Feb 20, 2026